首页> 外文期刊>Journal of atherosclerosis and thrombosis. >The status of lipid management in 1,836 patients with coronary artery disease: a multicenter survey to evaluate the percentage of Japanese coronary artery disease patients achieving the target low-density lipoprotein cholesterol level specified by th
【24h】

The status of lipid management in 1,836 patients with coronary artery disease: a multicenter survey to evaluate the percentage of Japanese coronary artery disease patients achieving the target low-density lipoprotein cholesterol level specified by th

机译:1,836例冠心病患者的血脂管理状况:一项多中心调查,评估达到目标的低密度脂蛋白胆固醇水平达到目标的日本冠心病患者的百分比

获取原文
获取原文并翻译 | 示例
       

摘要

To determine the status of lipid management in patients with coronary artery disease (CAD) in Japan, we assessed CAD patients who had been receiving lipid-lowering therapy for six months in a cross-sectional survey conducted between June 2001 and December 2002. We defined the achievement rate as the percentage of patients who achieved the target LDL-C level (< 100 mg/dl) specified by the Japan Atherosclerosis Society (JAS). A total of 1,836 Japanese CAD patients were enrolled. In total, 549 (29.9%) achieved the target level. The achievement rate among those receiving statin therapy was 41.3%, which was significantly higher than that (23.4%) among the patients not receiving statin (P < 0.0001). The rate differed with the type of statin; being 54.7% for atorvastatin, 24.8% for pravastatin, 37.1% for simvastatin, and 27.8% for fluvastatin. A multiple regression analysis revealed that atorvastatin use (P < 0.001), and simvastatin use (P = 0.004) significantly contributed to the achievement of the target LDL-C level. In conclusion, large proportions of CAD patients are not achieving the JAS target and the success rates are not similar among different statin therapies, suggesting that cardiologists should consider a more aggressive lipid-lowering therapy with the appropriate choice of statins in Japanese CAD patients.
机译:为了确定日本冠状动脉疾病(CAD)患者的血脂管理状况,我们在2001年6月至2002年12月进行的横断面调查中评估了接受降脂治疗六个月的CAD患者。达到率是达到日本动脉粥样硬化学会(JAS)规定的目标LDL-C水平(<100 mg / dl)的患者所占的百分比。共有1836名日本CAD患者入组。总计549(29.9%)实现了目标水平。接受他汀类药物治疗的患者的成功率为41.3%,显着高于未接受他汀类药物的患者的(23.4%)(P <0.0001)。速率随他汀类药物的类型而异。阿托伐他汀占54.7%,普伐他汀占24.8%,辛伐他汀占37.1%,氟伐他汀占27.8%。多元回归分析表明,使用阿托伐他汀(P <0.001)和辛伐他汀(P = 0.004)显着促进了目标LDL-C水平的实现。总而言之,不同比例的他汀类药物疗法中,有很大比例的CAD患者未达到JAS指标,成功率也不相似,这表明心脏病专家应考虑在日本的CAD患者中选择更合适的他汀类药物进行更积极的降脂治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号